Coinbase is reportedly finalizing negotiations for its most substantial acquisition to date—a strategic move valued at ...

Microsoft is navigating one of the most pivotal strategic shifts in its corporate history. The technology behemoth is ...

The publication of Regencell Bioscience's annual financial statements on Friday has cast serious doubt on the company's ...

The artificial intelligence sector's high-flying ambitions have encountered sobering reality, with C3.ai experiencing a ...

The Trade Desk is positioning itself for a renewed growth phase with the strategic appointment of a seasoned Google executive ...

The waiting is nearly over for Ocugen shareholders as the biopharmaceutical company prepares to release its third-quarter ...

The abrupt departure of Lyell Immunopharma's chief financial officer has created uncertainty about the biotechnology firm's ...

Pharmaceutical titan Eli Lilly has delivered a quarterly report that dramatically surpassed market forecasts, sending waves ...

The upcoming quarterly report from Synopsys, a dominant force in electronic design automation (EDA) software, represents the ...

The pharmaceutical sector is witnessing a high-stakes confrontation as Pfizer finds itself embroiled in a fierce bidding ...

Columbia Sportswear stock plummeted to a fresh 52-week low of $47.47 during Friday's trading session, driven by disappointing quarterly results and a cautious ...

Viking Therapeutics delivered a disappointing earnings report on October 22, revealing a quarterly loss of $0.81 per share that fell substantially short of ...